0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global P53 Antibody Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-21F8818
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global P53 Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global P53 Antibody Market Research Report 2025

Code: QYRE-Auto-21F8818
Report
July 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

P53 Antibody Market Size

The global market for P53 Antibody was valued at US$ 11.4 million in the year 2024 and is projected to reach a revised size of US$ 29.8 million by 2031, growing at a CAGR of 15.0% during the forecast period.

P53 Antibody Market

P53 Antibody Market

Antibodies are proteins that protect you when an unwanted substance enters your body.
A surge in research and development activities among pharmaceutical market leaders to develop economical andeffective antibodies and biosimilar antibodies is driving growth opportunities for the antibodies market.
This report aims to provide a comprehensive presentation of the global market for P53 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding P53 Antibody.
The P53 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global P53 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the P53 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of P53 Antibody Market Report

Report Metric Details
Report Name P53 Antibody Market
Accounted market size in year US$ 11.4 million
Forecasted market size in 2031 US$ 29.8 million
CAGR 15.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Enzyme Linked Immunosorbent Assay
  • Immunocytochemistry
  • Immunohistochemistry
  • Immunoprecipitation
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Aviva Systems Biology, Santa Cruz Biotechnology, Cell Signaling Technology, FineTest, Miltenyi Biotec, Merck, Atlas Antibodies, Proteintech, Boster Biological Technology, Bio-Rad, Medimabs, EXBIO, United States Biological, Beckman Coulter, Leica Biosystems, NSJ Bioreagents
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of P53 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is P53 Antibody Market growing?

Ans: The P53 Antibody Market witnessing a CAGR of 15.0% during the forecast period 2025-2031.

What is the P53 Antibody Market size in 2031?

Ans: The P53 Antibody Market size in 2031 will be US$ 29.8 million.

Who are the main players in the P53 Antibody Market report?

Ans: The main players in the P53 Antibody Market are Thermo Fisher Scientific, Aviva Systems Biology, Santa Cruz Biotechnology, Cell Signaling Technology, FineTest, Miltenyi Biotec, Merck, Atlas Antibodies, Proteintech, Boster Biological Technology, Bio-Rad, Medimabs, EXBIO, United States Biological, Beckman Coulter, Leica Biosystems, NSJ Bioreagents

What are the Application segmentation covered in the P53 Antibody Market report?

Ans: The Applications covered in the P53 Antibody Market report are Enzyme Linked Immunosorbent Assay, Immunocytochemistry, Immunohistochemistry, Immunoprecipitation, Others

What are the Type segmentation covered in the P53 Antibody Market report?

Ans: The Types covered in the P53 Antibody Market report are Polyclonal, Monoclonal

Recommended Reports

Antibody Markets

Antibody Therapeutics

Oncology & Protein Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global P53 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global P53 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Enzyme Linked Immunosorbent Assay
1.3.3 Immunocytochemistry
1.3.4 Immunohistochemistry
1.3.5 Immunoprecipitation
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global P53 Antibody Market Perspective (2020-2031)
2.2 Global P53 Antibody Growth Trends by Region
2.2.1 Global P53 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 P53 Antibody Historic Market Size by Region (2020-2025)
2.2.3 P53 Antibody Forecasted Market Size by Region (2026-2031)
2.3 P53 Antibody Market Dynamics
2.3.1 P53 Antibody Industry Trends
2.3.2 P53 Antibody Market Drivers
2.3.3 P53 Antibody Market Challenges
2.3.4 P53 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top P53 Antibody Players by Revenue
3.1.1 Global Top P53 Antibody Players by Revenue (2020-2025)
3.1.2 Global P53 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global P53 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by P53 Antibody Revenue
3.4 Global P53 Antibody Market Concentration Ratio
3.4.1 Global P53 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by P53 Antibody Revenue in 2024
3.5 Global Key Players of P53 Antibody Head office and Area Served
3.6 Global Key Players of P53 Antibody, Product and Application
3.7 Global Key Players of P53 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 P53 Antibody Breakdown Data by Type
4.1 Global P53 Antibody Historic Market Size by Type (2020-2025)
4.2 Global P53 Antibody Forecasted Market Size by Type (2026-2031)
5 P53 Antibody Breakdown Data by Application
5.1 Global P53 Antibody Historic Market Size by Application (2020-2025)
5.2 Global P53 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America P53 Antibody Market Size (2020-2031)
6.2 North America P53 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America P53 Antibody Market Size by Country (2020-2025)
6.4 North America P53 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe P53 Antibody Market Size (2020-2031)
7.2 Europe P53 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe P53 Antibody Market Size by Country (2020-2025)
7.4 Europe P53 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific P53 Antibody Market Size (2020-2031)
8.2 Asia-Pacific P53 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific P53 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific P53 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America P53 Antibody Market Size (2020-2031)
9.2 Latin America P53 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America P53 Antibody Market Size by Country (2020-2025)
9.4 Latin America P53 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa P53 Antibody Market Size (2020-2031)
10.2 Middle East & Africa P53 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa P53 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa P53 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific P53 Antibody Introduction
11.1.4 Thermo Fisher Scientific Revenue in P53 Antibody Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Aviva Systems Biology
11.2.1 Aviva Systems Biology Company Details
11.2.2 Aviva Systems Biology Business Overview
11.2.3 Aviva Systems Biology P53 Antibody Introduction
11.2.4 Aviva Systems Biology Revenue in P53 Antibody Business (2020-2025)
11.2.5 Aviva Systems Biology Recent Development
11.3 Santa Cruz Biotechnology
11.3.1 Santa Cruz Biotechnology Company Details
11.3.2 Santa Cruz Biotechnology Business Overview
11.3.3 Santa Cruz Biotechnology P53 Antibody Introduction
11.3.4 Santa Cruz Biotechnology Revenue in P53 Antibody Business (2020-2025)
11.3.5 Santa Cruz Biotechnology Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Details
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology P53 Antibody Introduction
11.4.4 Cell Signaling Technology Revenue in P53 Antibody Business (2020-2025)
11.4.5 Cell Signaling Technology Recent Development
11.5 FineTest
11.5.1 FineTest Company Details
11.5.2 FineTest Business Overview
11.5.3 FineTest P53 Antibody Introduction
11.5.4 FineTest Revenue in P53 Antibody Business (2020-2025)
11.5.5 FineTest Recent Development
11.6 Miltenyi Biotec
11.6.1 Miltenyi Biotec Company Details
11.6.2 Miltenyi Biotec Business Overview
11.6.3 Miltenyi Biotec P53 Antibody Introduction
11.6.4 Miltenyi Biotec Revenue in P53 Antibody Business (2020-2025)
11.6.5 Miltenyi Biotec Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck P53 Antibody Introduction
11.7.4 Merck Revenue in P53 Antibody Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Atlas Antibodies
11.8.1 Atlas Antibodies Company Details
11.8.2 Atlas Antibodies Business Overview
11.8.3 Atlas Antibodies P53 Antibody Introduction
11.8.4 Atlas Antibodies Revenue in P53 Antibody Business (2020-2025)
11.8.5 Atlas Antibodies Recent Development
11.9 Proteintech
11.9.1 Proteintech Company Details
11.9.2 Proteintech Business Overview
11.9.3 Proteintech P53 Antibody Introduction
11.9.4 Proteintech Revenue in P53 Antibody Business (2020-2025)
11.9.5 Proteintech Recent Development
11.10 Boster Biological Technology
11.10.1 Boster Biological Technology Company Details
11.10.2 Boster Biological Technology Business Overview
11.10.3 Boster Biological Technology P53 Antibody Introduction
11.10.4 Boster Biological Technology Revenue in P53 Antibody Business (2020-2025)
11.10.5 Boster Biological Technology Recent Development
11.11 Bio-Rad
11.11.1 Bio-Rad Company Details
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad P53 Antibody Introduction
11.11.4 Bio-Rad Revenue in P53 Antibody Business (2020-2025)
11.11.5 Bio-Rad Recent Development
11.12 Medimabs
11.12.1 Medimabs Company Details
11.12.2 Medimabs Business Overview
11.12.3 Medimabs P53 Antibody Introduction
11.12.4 Medimabs Revenue in P53 Antibody Business (2020-2025)
11.12.5 Medimabs Recent Development
11.13 EXBIO
11.13.1 EXBIO Company Details
11.13.2 EXBIO Business Overview
11.13.3 EXBIO P53 Antibody Introduction
11.13.4 EXBIO Revenue in P53 Antibody Business (2020-2025)
11.13.5 EXBIO Recent Development
11.14 United States Biological
11.14.1 United States Biological Company Details
11.14.2 United States Biological Business Overview
11.14.3 United States Biological P53 Antibody Introduction
11.14.4 United States Biological Revenue in P53 Antibody Business (2020-2025)
11.14.5 United States Biological Recent Development
11.15 Beckman Coulter
11.15.1 Beckman Coulter Company Details
11.15.2 Beckman Coulter Business Overview
11.15.3 Beckman Coulter P53 Antibody Introduction
11.15.4 Beckman Coulter Revenue in P53 Antibody Business (2020-2025)
11.15.5 Beckman Coulter Recent Development
11.16 Leica Biosystems
11.16.1 Leica Biosystems Company Details
11.16.2 Leica Biosystems Business Overview
11.16.3 Leica Biosystems P53 Antibody Introduction
11.16.4 Leica Biosystems Revenue in P53 Antibody Business (2020-2025)
11.16.5 Leica Biosystems Recent Development
11.17 NSJ Bioreagents
11.17.1 NSJ Bioreagents Company Details
11.17.2 NSJ Bioreagents Business Overview
11.17.3 NSJ Bioreagents P53 Antibody Introduction
11.17.4 NSJ Bioreagents Revenue in P53 Antibody Business (2020-2025)
11.17.5 NSJ Bioreagents Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global P53 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Polyclonal
 Table 3. Key Players of Monoclonal
 Table 4. Global P53 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global P53 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global P53 Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global P53 Antibody Market Share by Region (2020-2025)
 Table 8. Global P53 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global P53 Antibody Market Share by Region (2026-2031)
 Table 10. P53 Antibody Market Trends
 Table 11. P53 Antibody Market Drivers
 Table 12. P53 Antibody Market Challenges
 Table 13. P53 Antibody Market Restraints
 Table 14. Global P53 Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global P53 Antibody Market Share by Players (2020-2025)
 Table 16. Global Top P53 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P53 Antibody as of 2024)
 Table 17. Ranking of Global Top P53 Antibody Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by P53 Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of P53 Antibody, Headquarters and Area Served
 Table 20. Global Key Players of P53 Antibody, Product and Application
 Table 21. Global Key Players of P53 Antibody, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global P53 Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global P53 Antibody Revenue Market Share by Type (2020-2025)
 Table 25. Global P53 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global P53 Antibody Revenue Market Share by Type (2026-2031)
 Table 27. Global P53 Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global P53 Antibody Revenue Market Share by Application (2020-2025)
 Table 29. Global P53 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global P53 Antibody Revenue Market Share by Application (2026-2031)
 Table 31. North America P53 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America P53 Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America P53 Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe P53 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe P53 Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe P53 Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific P53 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific P53 Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific P53 Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America P53 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America P53 Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America P53 Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa P53 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa P53 Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa P53 Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Thermo Fisher Scientific Company Details
 Table 47. Thermo Fisher Scientific Business Overview
 Table 48. Thermo Fisher Scientific P53 Antibody Product
 Table 49. Thermo Fisher Scientific Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 50. Thermo Fisher Scientific Recent Development
 Table 51. Aviva Systems Biology Company Details
 Table 52. Aviva Systems Biology Business Overview
 Table 53. Aviva Systems Biology P53 Antibody Product
 Table 54. Aviva Systems Biology Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 55. Aviva Systems Biology Recent Development
 Table 56. Santa Cruz Biotechnology Company Details
 Table 57. Santa Cruz Biotechnology Business Overview
 Table 58. Santa Cruz Biotechnology P53 Antibody Product
 Table 59. Santa Cruz Biotechnology Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 60. Santa Cruz Biotechnology Recent Development
 Table 61. Cell Signaling Technology Company Details
 Table 62. Cell Signaling Technology Business Overview
 Table 63. Cell Signaling Technology P53 Antibody Product
 Table 64. Cell Signaling Technology Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 65. Cell Signaling Technology Recent Development
 Table 66. FineTest Company Details
 Table 67. FineTest Business Overview
 Table 68. FineTest P53 Antibody Product
 Table 69. FineTest Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 70. FineTest Recent Development
 Table 71. Miltenyi Biotec Company Details
 Table 72. Miltenyi Biotec Business Overview
 Table 73. Miltenyi Biotec P53 Antibody Product
 Table 74. Miltenyi Biotec Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 75. Miltenyi Biotec Recent Development
 Table 76. Merck Company Details
 Table 77. Merck Business Overview
 Table 78. Merck P53 Antibody Product
 Table 79. Merck Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 80. Merck Recent Development
 Table 81. Atlas Antibodies Company Details
 Table 82. Atlas Antibodies Business Overview
 Table 83. Atlas Antibodies P53 Antibody Product
 Table 84. Atlas Antibodies Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 85. Atlas Antibodies Recent Development
 Table 86. Proteintech Company Details
 Table 87. Proteintech Business Overview
 Table 88. Proteintech P53 Antibody Product
 Table 89. Proteintech Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 90. Proteintech Recent Development
 Table 91. Boster Biological Technology Company Details
 Table 92. Boster Biological Technology Business Overview
 Table 93. Boster Biological Technology P53 Antibody Product
 Table 94. Boster Biological Technology Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 95. Boster Biological Technology Recent Development
 Table 96. Bio-Rad Company Details
 Table 97. Bio-Rad Business Overview
 Table 98. Bio-Rad P53 Antibody Product
 Table 99. Bio-Rad Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 100. Bio-Rad Recent Development
 Table 101. Medimabs Company Details
 Table 102. Medimabs Business Overview
 Table 103. Medimabs P53 Antibody Product
 Table 104. Medimabs Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 105. Medimabs Recent Development
 Table 106. EXBIO Company Details
 Table 107. EXBIO Business Overview
 Table 108. EXBIO P53 Antibody Product
 Table 109. EXBIO Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 110. EXBIO Recent Development
 Table 111. United States Biological Company Details
 Table 112. United States Biological Business Overview
 Table 113. United States Biological P53 Antibody Product
 Table 114. United States Biological Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 115. United States Biological Recent Development
 Table 116. Beckman Coulter Company Details
 Table 117. Beckman Coulter Business Overview
 Table 118. Beckman Coulter P53 Antibody Product
 Table 119. Beckman Coulter Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 120. Beckman Coulter Recent Development
 Table 121. Leica Biosystems Company Details
 Table 122. Leica Biosystems Business Overview
 Table 123. Leica Biosystems P53 Antibody Product
 Table 124. Leica Biosystems Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 125. Leica Biosystems Recent Development
 Table 126. NSJ Bioreagents Company Details
 Table 127. NSJ Bioreagents Business Overview
 Table 128. NSJ Bioreagents P53 Antibody Product
 Table 129. NSJ Bioreagents Revenue in P53 Antibody Business (2020-2025) & (US$ Million)
 Table 130. NSJ Bioreagents Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. P53 Antibody Picture
 Figure 2. Global P53 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global P53 Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Polyclonal Features
 Figure 5. Monoclonal Features
 Figure 6. Global P53 Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global P53 Antibody Market Share by Application: 2024 VS 2031
 Figure 8. Enzyme Linked Immunosorbent Assay Case Studies
 Figure 9. Immunocytochemistry Case Studies
 Figure 10. Immunohistochemistry Case Studies
 Figure 11. Immunoprecipitation Case Studies
 Figure 12. Others Case Studies
 Figure 13. P53 Antibody Report Years Considered
 Figure 14. Global P53 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global P53 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global P53 Antibody Market Share by Region: 2024 VS 2031
 Figure 17. Global P53 Antibody Market Share by Players in 2024
 Figure 18. Global Top P53 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P53 Antibody as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by P53 Antibody Revenue in 2024
 Figure 20. North America P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America P53 Antibody Market Share by Country (2020-2031)
 Figure 22. United States P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe P53 Antibody Market Share by Country (2020-2031)
 Figure 26. Germany P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific P53 Antibody Market Share by Region (2020-2031)
 Figure 34. China P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America P53 Antibody Market Share by Country (2020-2031)
 Figure 42. Mexico P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa P53 Antibody Market Share by Country (2020-2031)
 Figure 46. Turkey P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE P53 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 50. Aviva Systems Biology Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 51. Santa Cruz Biotechnology Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 52. Cell Signaling Technology Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 53. FineTest Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 54. Miltenyi Biotec Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 55. Merck Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 56. Atlas Antibodies Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 57. Proteintech Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 58. Boster Biological Technology Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 59. Bio-Rad Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 60. Medimabs Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 61. EXBIO Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 62. United States Biological Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 63. Beckman Coulter Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 64. Leica Biosystems Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 65. NSJ Bioreagents Revenue Growth Rate in P53 Antibody Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart